FDA Authorizes Philip Morris to Market Zyn Nicotine Pouches as Less Harmful Than Cigarettes

Jun 30, 2026

On June 30, 2026, the FDA cleared Philip Morris-owned Zyn to market 20 nicotine pouch variants as less harmful than cigarettes, allowing claims that switching lowers the risk of diseases like lung cancer and stroke. This regulatory victory comes amid a broader Trump administration shift toward loosening nicotine restrictions following industry lobbying. Zyn has surged in popularity, with Philip Morris selling 794 million cans in 2025, making it a major cultural and market force.

FDA modified-risk authorization for Zyn

▪The Food and Drug Administration cleared Philip Morris-owned Zyn nicotine pouches to be marketed as less harmful than cigarettes on June 30, 2026.
▪The Food and Drug Administration decision allows 20 Zyn product variants to carry a modified-risk claim stating that switching from cigarettes to Zyn lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.
▪The 20 Zyn products covered by the Food and Drug Administration order include Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen in 3-milligram and 6-milligram strengths.
▪The Food and Drug Administration authorized the same 20 Zyn products for sale in January 2025, but that decision did not allow Swedish Match to market them as reducing disease risk.

Trump administration nicotine policy shift

▪The Trump administration has created a pathway for some flavored e-cigarettes and nicotine pouches to remain on the market while undergoing Food and Drug Administration review.
▪Tobacco and vaping industries have heavily lobbied United States President Donald Trump and other key officials for changes including a faster, clearer Food and Drug Administration authorization process.

Zyn cultural significance among conservatives

▪Health and Human Services Secretary Robert F. Kennedy Jr. reportedly uses nicotine pouches, and United States President Donald Trump recently asked Robert F. Kennedy Jr. which pouches he used.
▪Zyn nicotine pouches have surged in popularity among conservatives, tech workers, and others who promote them as a cleaner alternative to cigarettes or a productivity aid.

Philip Morris smoke-free product strategy

▪Philip Morris is investing more heavily in smoke-free products as cigarette sales continue to decline in the United States.
▪Philip Morris cut its annual profit forecast for the second time in June 2026, though Chief Executive Officer Jacek Olczak called recent Food and Drug Administration moves to relax enforcement a net positive.

Nicotine pouch market growth

▪Nicotine pouches are the fastest-growing nicotine product in the United States, with millions of users.
▪Philip Morris sold 794 million cans of Zyn in the United States in 2025, which was more than double its 2023 sales.